GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Synthetic organic
Comment: G0775 is an optimized arylomycin derivative with promising in vitro antibacterial activity against multidrug-resistant (MDR) Gram-negative bacteria [1].
|
|
Bioactivity Comments |
G0775 is at least 500-fold more potent than arylomycin against the ESKAPE pathogen Klebsiella pneumoniae. The MIC for in vitro antibacterial activity against MDR K. pneumoniae CDC 0106 is 0.5 μg/ml [1]. G0775 also demonstrates antibacterial activity against certain Gram-positive bacteria, including Staphylococcus epidermidis (MIC of 0.25 μg/ml) and Staphylococcus aureus (MIC of 0.06 μg/ml) [1]. |